OSE-CYTOMASK Trademark

Trademark Overview


On Monday, July 24, 2023, a trademark application was filed for OSE-CYTOMASK with the United States Patent and Trademark Office. The USPTO has given the OSE-CYTOMASK trademark a serial number of 98098883. The federal status of this trademark filing is REGISTERED as of Tuesday, May 6, 2025. This trademark is owned by OSE Immunotherapeutics. The OSE-CYTOMASK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies
ose-cytomask

General Information


Serial Number98098883
Word MarkOSE-CYTOMASK
Filing DateMonday, July 24, 2023
Status700 - REGISTERED
Status DateTuesday, May 6, 2025
Registration Number7782135
Registration DateTuesday, May 6, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements


Goods and ServicesScientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOSE Immunotherapeutics
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressNantes 44200
FR

Party NameOSE Immunotherapeutics
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressNantes 44200
FR

Party NameOSE Immunotherapeutics
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressNantes 44200
FR

Trademark Events


Event DateEvent Description
Thursday, July 27, 2023NEW APPLICATION ENTERED
Tuesday, August 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 26, 2023ASSIGNED TO EXAMINER
Tuesday, November 5, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, November 8, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, November 28, 2023SUSPENSION LETTER WRITTEN
Tuesday, November 28, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, November 28, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 25, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, November 5, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, November 5, 2024INQUIRY TO SUSPENSION E-MAILED
Thursday, December 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2024ASSIGNED TO LIE
Thursday, January 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 6, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 6, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION